<?xml version="1.0" encoding="UTF-8"?>
<p id="p0285">ACE2 expression has been shown to be upregulated by infection with SARS-CoV-2 (
 <xref rid="bib175" ref-type="bibr">Wang and Cheng, 2020</xref>). However, the relation between ACE2 and SARS-CoV-2 virulence is complex and it is attracting extreme interest currently (
 <xref rid="bib65" ref-type="bibr">Hoffmann et al., 2020</xref>), following concern about the potential ability of some anti-hypertensive drugs, such as ACE-inhibitors and angiotensin-receptor blockers (ARBs) to increase Covid-19 severity and case fatality rate (
 <xref rid="bib31" ref-type="bibr">Day, 2020</xref>). This is a clear example of environmental toxins laying the groundwork for increased susceptibility to COVID-19 (and other viral diseases), and subsequent treatments exacerbating the severity of COVID-19, and is why elimination of the environmental toxin is the much preferred route.
</p>
